MCM
MNTA

Moore Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Moore Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100,000
Closed -$5.25M – 672
2020
Q3 		$5.25M Buy
+100,000
New +$4.14M 0.1% 178

Moore Capital Management's MNTA Position: Q1 2020 in Review

Moore Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 78,952 shares — an estimated $1.56M sold.

Moore Capital Management first reported a position in MNTA in Q4 2019 and held it in 1 quarter. The position peaked at $1.56M in Q4 2019. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

  • Moore Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Moore Capital Management sold 78,952 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.56M.
  • Moore Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2019 and held it in 1 quarter.
  • Moore Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.56M in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Moore Capital Management's 13F filing for Q1 2020, filed 15 May 2020.